These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34719625)

  • 21. Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study.
    Coffin SE; Leckerman K; Keren R; Hall M; Localio R; Zaoutis TE
    Pediatr Infect Dis J; 2011 Nov; 30(11):962-6. PubMed ID: 21997661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuraminidase inhibitors for critically ill children with influenza.
    Louie JK; Yang S; Samuel MC; Uyeki TM; Schechter R
    Pediatrics; 2013 Dec; 132(6):e1539-45. PubMed ID: 24276847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Oseltamivir in reducing 30-day readmissions and mortality among patients with severe seasonal influenza in Australian hospitalized patients.
    Sharma Y; Horwood C; Hakendorf P; Thompson C
    Int J Infect Dis; 2021 Mar; 104():232-238. PubMed ID: 33434667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study.
    Blumentals WA; Schulman KL
    Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
    Komeda T; Takazono T; Hosogaya N; Ogura E; Fujiwara M; Miyauchi H; Ajisawa Y; Iwata S; Watanabe H; Honda K; Kitanishi Y; Hara K; Mukae H
    Clin Infect Dis; 2021 Jun; 72(11):e859-e867. PubMed ID: 33103200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study.
    Chen L; Han X; Li YL; Zhang C; Xing X
    BMC Infect Dis; 2020 Aug; 20(1):628. PubMed ID: 32842994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.
    Hirotsu N; Saisho Y; Hasegawa T
    Influenza Other Respir Viruses; 2019 Mar; 13(2):123-132. PubMed ID: 29989680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.
    Shun-Shin M; Thompson M; Heneghan C; Perera R; Harnden A; Mant D
    BMJ; 2009 Aug; 339():b3172. PubMed ID: 19666987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.
    Tamura D; Sugaya N; Ozawa M; Takano R; Ichikawa M; Yamazaki M; Kawakami C; Shimizu H; Uehara R; Kiso M; Kawakami E; Mitamura K; Kawaoka Y
    Clin Infect Dis; 2011 Feb; 52(4):432-7. PubMed ID: 21248368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution Analysis via Mass Spectrometry Imaging of Ephedrine in the Lungs of Rats Orally Administered the Japanese Kampo Medicine Maoto.
    Matsumoto T; Kushida H; Matsushita S; Oyama Y; Suda T; Watanabe J; Kase Y; Setou M
    Sci Rep; 2017 Mar; 7():44098. PubMed ID: 28272490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes.
    Katzen J; Kohn R; Houk JL; Ison MG
    Clin Infect Dis; 2019 Jun; 69(1):52-58. PubMed ID: 30304487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
    Jefferson T; Jones M; Doshi P; Del Mar C
    BMJ; 2009 Dec; 339():b5106. PubMed ID: 19995812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].
    Aver'ianov AV; Babkin AP; Bart BIa; Volchetskiĭ AL; Minina ES; Kozyrev OA; Kostinov MP; Petrov DV; Sel'kova EP; Putilovskiĭ MA; Nechaev VB; Epshteĭn OI; Andrianova EN
    Antibiot Khimioter; 2012; 57(7-8):23-30. PubMed ID: 23350191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan.
    Takashita E; Fujisaki S; Kishida N; Xu H; Imai M; Tashiro M; Odagiri T;
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1390-9. PubMed ID: 23745712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antiviral treatment on influenza-related complications over four influenza seasons: 2006-2010.
    Spagnuolo PJ; Zhang M; Xu Y; Han J; Liu S; Liu J; Lichtveld M; Shi L
    Curr Med Res Opin; 2016 Aug; 32(8):1399-407. PubMed ID: 27052817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza A (H1N1).
    Ohnishi K; Nakamura-Uchiyama F
    J Infect Chemother; 2010 Feb; 16(1):62-3. PubMed ID: 20072797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
    Harada N; Shibata W; Koh H; Takashita E; Fujisaki S; Okamura H; Nanno S; Yamada K; Nakamae H; Hino M; Kakeya H
    BMC Infect Dis; 2020 Jul; 20(1):478. PubMed ID: 32631240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro neuraminidase inhibitory concentration (IC
    Ikematsu H; Kawai N; Chong Y; Bando T; Iwaki N; Kashiwagi S
    J Infect Chemother; 2019 Aug; 25(8):649-652. PubMed ID: 31101530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.